New Key Statistics Module, Z-Score and F-Score
OTCPK:MVRBF Key Ratios
| Market Cap $ M | 38.49 |
| Enterprise Value $ M | 28.98 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.14 |
| Price/Sales | 32.53 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -3.04 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 28.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.24 |
| EV-to-EBITDA | -1.27 |
| PEG | -- |
| Shares Outstanding M | 55.83 |
| Net Margin (%) | -1,686.21 |
| Operating Margin % | -1,767.41 |
| Pre-tax Margin (%) | -1,686.21 |
| Quick Ratio | 1.84 |
| Current Ratio | 1.84 |
| ROA % (ttm) | -49.80 |
| ROE % (ttm) | -67.06 |
| ROIC % (ttm) | -79.34 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.39 |
MVRBF Number of Guru Trades
MVRBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MVRBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MVRBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Medivir AB Insider Transactions
No Available Data
News about OTCPK:MVRBF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers